WANY
NEO icon

Wealthspire Advisors (New York)’s NeoGenomics NEO Stock Holding History

Wealthspire Advisors (New York)’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-115
Closed -$888 – 2217
2025
Q3 		$888 Buy
+115
New +$806 ﹤0.01% 2758

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Wealthspire Advisors (New York)'s NEO Position: Q4 2025 in Review

Wealthspire Advisors (New York) sold out of NeoGenomics (NEO) in Q4 2025, closing a stake of 115 shares — an estimated $888 sold.

Wealthspire Advisors (New York) first reported a position in NEO in Q3 2025 and held it in 1 quarter. The position peaked at $888 in Q3 2025. 256 funds tracked by Wall St. Rank hold NEO as of Q4 2025.

  • Wealthspire Advisors (New York) reported no remaining NeoGenomics position as of Q4 2025 after selling out during the quarter.
  • Wealthspire Advisors (New York) sold 115 NeoGenomics shares in Q4 2025, an estimated $888.
  • Wealthspire Advisors (New York) first reported a position in NeoGenomics in Q3 2025 and held it in 1 quarter.
  • Wealthspire Advisors (New York)'s NeoGenomics position peaked at $888 in Q3 2025.
  • 256 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2025.

Based on Wealthspire Advisors (New York)'s 13F filing for Q4 2025, filed 13 Feb 2026.